Timothy R McLevish

Director Timothy R McLevish bought 3,000 shares of FRPT at $48.67 on 2026-05-18; stock down -47.2% from 52-week high, cluster buy pattern detected.

Timothy R McLevish, a Director, purchased 3,000 shares at $48.67, increasing his holdings from 36,879 to 39,879 shares (+8.1%). The purchase occurs as FRPT trades at $47.39 current price, down -31.8% in 30 days and -35.1% in 90 days from purchase, positioning the stock -47.2% below its 52-week high of $89.80. His cross-ticker track record shows 8 prior open-market buys with a 12.50% 90-day win rate and average 90-day return of -13.1%; his same-ticker history at FRPT is mixed, with only 1 of 5 prior buys showing a positive 90-day return (+15.4% on the 2025-09-10 purchase), while the other four posted losses ranging from -9.1% to -20.8%. Fundamentals remain solid: $297.6M quarterly revenue with +13.0% annual growth and a P/E of 11.62. A cluster buy pattern is present, with 2 other insiders also purchasing within the past 14 days, though this does not explain the director's specific motivation.

Director Timothy McLeVish buys 3,500 shares of FRPT at $56.00; stock now $53.20, down 67.3% from 52-week high

Director Timothy McLeVish purchased 3,500 shares of Freshpet (FRPT) at $56.00 on 2025-09-10, increasing his holdings by 11.0% to 35,290 shares total for $196,000 in value. This purchase occurs in a context of significant stock weakness: the current price of $53.20 is 67.3% below the 52-week high of $162.59, and the stock has declined 15.2% over 30 days and 28.4% over 90 days. Notably, McLeVish's prior transaction history at this ticker shows a 0 out of 5 well-timed buy pattern over 90-day periods, with his five previous purchases all resulting in negative 90-day returns ranging from -9.1% to -20.8%, suggesting he has not demonstrated skill at identifying entry points in FRPT. A cluster pattern is also present, with 4 other insiders buying within the past 14 days, though this does not itself indicate positive intent given the cumulative track record evidence.

Director MCLEVISH TIMOTHY R bought 1,750 shares at blended $88.47 on 2025-03-14; stock -45.1% from 52-week high.

Director MCLEVISH TIMOTHY R purchased 1,750 shares across two separate transactions totaling $154,815.00, expanding his holdings from 30,040 to 31,790 shares. The purchases occurred at $88.20 and $89.13 per share, with a blended average of $88.47, just 1.2% below the current price of $89.32. The acquisition pattern reflects recent accumulation activity: the director also filed five prior buy transactions at Freshpet on 2025-02-24 and 2025-02-25, indicating sustained interest in building his position. However, the broader stock context is challenging—the shares are -45.1% from the 52-week high of $162.59 and down -31.1% over 30 days and -39.0% over 90 days, suggesting this purchase occurs during a period of significant price decline. Freshpet's fundamentals show resilience (revenue $253,367,000.00, net income $11,895,000.00, annual revenue growth +27.2%, P/E 34.89) but do not clarify the driver of recent equity weakness.

Director MCLEVISH TIMOTHY R buys 2,000 shares at blended $104.82; 5 other insiders bought in past 14 days.

MCLEVISH TIMOTHY R executed 5 separate purchases totaling 2,000 shares for $209,640.00 over February 24-25, 2025, at prices ranging from $102.50 to $106.67 per share. This activity occurs within a cluster pattern: 5 other insiders also purchased within the past 14 days, suggesting coordinated or at least parallel conviction among multiple board/executive members. The stock has declined 34.3% from its 52-week high of $162.59 and is down 33.4% over the past 30 days, meaning these purchases follow significant price deterioration. The company's fundamentals remain solid: revenue growth of 27.2% year-over-year, positive net income of $11.9M, and a market cap of $5.2B, though the elevated P/E of 41.75 reflects historical valuation. The cluster buy pattern during a material drawdown warrants investor attention to what insiders are seeing that prompted simultaneous accumulation.